世界の生検ガイダンスシステムの市場規模は予測期間中5.2％のCAGRで推移し、2028年には13億8,350万USドルの規模に成長すると予測されています。癌の罹患率の増加、高齢者人口の増加、非侵襲的処置に対する需要の高まり、技術革新、政府の取り組みの増加、新型コロナウイルス感染症（COVID-19）の影響などの要因が同市場の成長を推進しています。
生検は、他の慢性疾患の中でも癌を診断するための最も著名な手順の1つであり、乳癌、脳腫瘍、皮膚癌、および前立腺癌の診断に一般的に使用されています。癌の罹患率の増加は、市場成長の大きな要因となっています。例えば、Cancer.orgによると、2021年にはアメリカで約190万人の癌患者が新たに診断されると予想されています。生検ガイダンスシステムは、癌の初期診断に必要なものの一つであるため、癌患者数の増加は、予測期間中の市場成長を促進すると予想されます。
さらに、この市場では、低侵襲の生検治療への関心が高まっています。予測期間中、ロボット支援型生検ガイダンスシステム、ニードルベースの生検ガン、真空支援型コア生検システムなど、いくつかのタイプの技術や製品が急速に拡大すると予想されます。例えば、2021年3月、IZI Medical Products, LLC社は、軟部組織生検用のクイックコア自動生検システム（Quick-Core Auto Biopsy System）を発売しました。これは、軽量で完全自動の生検装置で、信頼性、品質、精度を提供します。さらに、乳癌の治療と診断に対する意識の高まりが、予測期間中の市場成長をさらに後押しするでしょう。
目次
Table of Contents
Chapter 1 Research Methodology
1.1 Research Methodology
1.1.1 Information procurement
1.2 Information or Data Analysis
1.3 Market Formulation & Validation
1.4 Region Wise Market Calculation
1.4.1 Region Wise Market: Base Estimates
1.4.2 Global Market: CAGR Calculation
1.5 Region Based Segment Share Calculation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.2 Volume price analysis (Model 2)
1.7 List of Secondary Sources
Chapter 2 Objectives
2.1 Objective - 1:
2.2 Objective - 2:
2.3 Objective - 3:
2.4 Objective - 4:
Chapter 3 Executive Summary
3.1 Market Outlook
3.2 Segment Outlook
3.3 Competitive Insights
3.3.1 Market Segmentation
3.4 Market Snapshot
Chapter 4 Biopsy Guidance Systems Market Variables, Trends & Scope
4.1 Market Lineage Outlook
4.1.1 Parent market outlook
4.1.2 Ancillary Market
4.2 Penetration & Growth Prospect Mapping
4.3 Regulatory Framework
4.4 Market Dynamics
4.4.1 Market driver analysis
4.4.1.1 Rising prevalence of cancer
4.4.1.2 Increasing preference for non-invasive procedures
4.4.1.3 Technological advancements
4.4.2 Market restraint analysis
4.4.2.1 Stringent manufacturing policies
4.4.2.2 High cost of biopsy guidance systems
4.5 Biopsy Guidance Systems Market Analysis Tools
4.5.1 SWOT Analysis, by PEST
4.5.2 Porter's five forces analysis
Chapter 5 Biopsy Guidance Systems Market: Segment Analysis, By Product, 2016 - 2028 (USD Million)
5.1 Definitions & Scope
5.2 Product Market Share Analysis, 2020 & 2028
5.3 Biopsy Guidance Systems Market, by Product, 2016 to 2028
5.4 Market Size Forecasts and Trend Analysis
5.4.1 Stereotactic guided biopsy
5.4.1.1 Stereotactic guided biopsy market, 2016 - 2028 (USD Million)
5.4.2 Ultrasound guided biopsy
5.4.2.1 Ultrasound guided biopsy market, 2016 - 2028 (USD Million)
5.4.3 MRI guided biopsy
5.4.3.1 MRI guided biopsy market, 2016 - 2028 (USD Million)
Chapter 6 Biopsy Guidance Systems Market: Segment Analysis, By Application, 2016 - 2028 (USD Million)
6.1 Definitions & Scope
6.2 Application Market Share Analysis, 2020 & 2028
6.3 Biopsy Guidance Systems Market, by Application, 2016 to 2028
6.4 Market Size Forecasts and Trend Analysis
6.4.1 Brain biopsy
6.4.1.1 Brain biopsy market, 2016 - 2028 (USD Million)
6.4.2 Breast biopsy
6.4.2.1 Breast biopsy market, 2016 - 2028 (USD Million)
6.4.3 Other applications
6.4.3.1 Other applications market, 2016 - 2028 (USD Million)
Chapter 7 Biopsy Guidance Systems Market: Segment Analysis, By End Use, 2016 - 2028 (USD Million)
7.1 Definitions & Scope
7.2 End-use Market Share Analysis, 2020 & 2028
7.3 Biopsy Guidance Systems Market, By End Use, 2016 to 2028
7.4 Market Size Forecasts and Trend Analysis
7.4.1 Hospitals
7.4.1.1 Hospitals market, 2016 - 2028 (USD Million)
7.4.2 Specialty clinics
7.4.2.1 Specialty clinics market, 2016 - 2028 (USD Million)
7.4.3 Diagnostic centers
7.4.3.1 Diagnostic centers market, 2016 - 2028 (USD Million)
7.4.4 Research and academic institutes
7.4.4.1 Research and academic institutes market, 2016 - 2028 (USD Million)
Chapter 8 Biopsy Guidance Systems Market: Regional Market Analysis, By Product, Application, and End-use, 2016 - 2028 (USD Million)
8.1 Definitions & Scope
8.2 Regional Market Share Analysis, 2020 & 2028
8.3 Regional Market Snapshot
8.4 Market Size Forecasts & Trend Analysis
8.4.1 North America
8.4.1.1 North America biopsy guidance systems market, 2016 - 2028 (USD Million)
8.4.1.2 U.S.
8.4.1.2.1 U.S. biopsy guidance systems market, 2016 - 2028 (USD Million)
8.4.1.3 Canada
8.4.1.3.1 Canada biopsy guidance systems market, 2016 - 2028 (USD Million)
8.4.2 Europe
8.4.2.1 Europe biopsy guidance systems market, 2016 - 2028 (USD Million)
8.4.2.2 U.K.
8.4.2.2.1 U.K. biopsy guidance systems market, 2016 - 2028 (USD Million)
8.4.2.3 Germany
8.4.2.3.1 Germany biopsy guidance systems market, 2016 - 2028 (USD Million)
8.4.3 Asia Pacific
8.4.3.1 Asia Pacific biopsy guidance systems market, 2016 - 2028 (USD Million)
8.4.3.2 Japan
8.4.3.2.1 Japan biopsy guidance systems market, 2016 - 2028 (USD Million)
8.4.3.3 China
8.4.3.3.1 China biopsy guidance systems market, 2016 - 2028 (USD Million)
8.4.4 Latin America
8.4.4.1 Latin America biopsy guidance systems market, 2016 - 2028 (USD Million)
8.4.4.2 Brazil
8.4.4.2.1 Brazil biopsy guidance systems market, 2016 - 2028 (USD Million)
8.4.4.3 Mexico
8.4.4.3.1 Mexico biopsy guidance systems market, 2016 - 2028 (USD Million)
8.4.5 Middle East & Africa
8.4.5.1 Middle East & Africa biopsy guidance systems market, 2016 - 2028 (USD Million)
8.4.5.2 South Africa
8.4.5.2.1 South Africa biopsy guidance systems market, 2016 - 2028 (USD Million)
8.4.5.3 Saudi Arabia
8.4.5.3.1 Saudi Arabia biopsy guidance systems market, 2016 - 2028 (USD Million)
Chapter 9 Biopsy Guidance Systems Market: Competitive Analysis
9.1 Company Profiles
9.1.1 Becton, Dickinson and Company
9.1.1.1 Company overview
9.1.1.2 Financial performance
9.1.1.3 Product benchmarking
9.1.1.4 Strategic initiatives
9.1.2 Hologic, Inc.
9.1.2.1 Company overview
9.1.2.2 Financial performance
9.1.2.3 Product benchmarking
9.1.2.4 Strategic initiatives
9.1.3 Devicor Medical Products, Inc.
9.1.3.1 Company overview
9.1.3.2 Financial performance
9.1.3.3 Product benchmarking
9.1.3.4 Strategic initiatives
9.1.4 B. Braun Melsungen AG
9.1.4.1 Company overview
9.1.4.2 Financial performance
9.1.4.3 Product benchmarking
9.1.4.4 Strategic initiatives
9.1.5 ARGON MEDICAL
9.1.5.1 Company overview
9.1.5.2 Financial performance
9.1.5.3 Product benchmarking
9.1.5.4 Strategic initiatives
9.1.6 Boston Scientific Corporation
9.1.6.1 Company overview
9.1.6.2 Financial performance
9.1.6.3 Product benchmarking
9.1.6.4 Strategic initiatives
9.1.7 INRAD Inc.
9.1.7.1 Company overview
9.1.7.2 Financial performance
9.1.7.3 Product benchmarking
9.1.7.4 Strategic initiatives
9.1.8 Cook Medical
9.1.8.1 Company overview
9.1.8.2 Financial performance
9.1.8.3 Product benchmarking
9.1.8.4 Strategic initiatives
9.1.9 PLANMED OY
9.1.9.1 Company overview
9.1.9.2 Financial performance
9.1.9.3 Product benchmarking
9.1.9.4 Strategic initiatives
